Prostate-specific antigen after neoadjuvant androgen suppression in prostate cancer patients receiving short-term androgen suppression and external beam radiotherapy: pooled analysis of four NRG Oncology RTOG randomized clinical trials

PURPOSE: To validate if prostate specific antigen (PSA) level after neoadjuvant androgen suppression (neoAS) is associated with long-term outcome after neoAS and external radiation therapy (RT) with concurrent short-term AS in prostate cancer patients. METHODS: 2404 patients treated with neoAS prior...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Pubblicato in:Int J Radiat Oncol Biol Phys
Autori principali: Hallemeier, Christopher L, Zhang, Peixin, Pisansky, Thomas M, Hanks, Gerald E, McGowan, David G, Roach, Mack, Zeitzer, Kenneth L, Firat, Selim Y, Husain, Siraj M, D’Souza, David P, Souhami, Luis, Parliament, Matthew B., Rosenthal, Seth A, Lukka, Himanshu R, Rotman, Marvin, Horwitz, Eric M, Miles, Edward F, Paulus, Rebecca, Sandler, Howard M
Natura: Artigo
Lingua:Inglês
Pubblicazione: 2019
Soggetti:
Article
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC6646073/
https://ncbi.nlm.nih.gov/pubmed/30959123
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.ijrobp.2019.03.049
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi